Experienced in Pneumonia

Antonis Valachis

Oerebro, T, SE 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Pneumonia
Oerebro, T, SE 
OverviewLocationsClinical Research

Overview

Antonis Valachis practices in Oerebro, Sweden. Mr. Valachis is rated as an Experienced expert by MediFind in the treatment of Pneumonia. His top areas of expertise are Breast Cancer, Pneumocystis Jiroveci Pneumonia, Hypothyroidism, Pneumonia, and Mastectomy.

His clinical research consists of co-authoring 71 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 5 articles in the study of Pneumonia.

Gender
Male

Locations

Oerebro, T, Sweden
Other Locations
Uppsala, C, Sweden
Mälarsjukhuset
Eskilstuna, D, Sweden
Solna, AB 17176, Sweden
Stockholm, AB, Sweden

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Prospective Randomized Multicenter Trial to Assess the Role of Imaging During Follow Up After Radical Surgery of Stage IIb-c and III Cutaneous Malignant Melanoma
A Prospective Randomized Multicenter Trial to Assess the Role of Imaging During Follow Up After Radical Surgery of Stage IIb-c and III Cutaneous Malignant Melanoma
Enrollment Status: Recruiting
Publish Date: December 16, 2024
Intervention Type: Procedure
Study Phase: Not Applicable
A Translational Randomized Phase III Study Exploring the Effect of the Addition of Capecitabine to Carboplatine Based Chemotherapy in Early Triple Negative Breast Cancer
A Translational Randomized Phase III Study Exploring the Effect of the Addition of Capecitabine to Carboplatine Based Chemotherapy in Early Triple Negative Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 12, 2025
Intervention Type: Drug
Study Drugs: epirubicin, cyclophosphamide, paclitaxel, carboplatin, capecitabine
Study Phase: Phase 3
postMONARCH: A Randomized, Double Blind, Placebo-Controlled, Phase 3 Study to Compare the Efficacy of Abemaciclib Plus Fulvestrant to Placebo Plus Fulvestrant in Participants With HR+, HER2-, Advanced or Metastatic Breast Cancer Following Progression on a CDK4 & 6 Inhibitor and Endocrine Therapy
postMONARCH: A Randomized, Double Blind, Placebo-Controlled, Phase 3 Study to Compare the Efficacy of Abemaciclib Plus Fulvestrant to Placebo Plus Fulvestrant in Participants With HR+, HER2-, Advanced or Metastatic Breast Cancer Following Progression on a CDK4 & 6 Inhibitor and Endocrine Therapy
Enrollment Status: Active_not_recruiting
Publish Date: April 18, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Fulvestrant
Study Phase: Phase 3
View 2 Less Clinical Trial

71 Total Publications

ESMO Basic Requirements for AI-based Biomarkers In Oncology (EBAI).
ESMO Basic Requirements for AI-based Biomarkers In Oncology (EBAI).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 16, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Valachis's expertise for a condition
ConditionClose
    View All 8 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile